Serge Monpoeho currently serves as the Senior Director of Quality Control (QC) at Regeneron Pharmaceuticals Inc., where he leverages his extensive technical knowledge and experience in the biopharmaceutical industry to ensure the highest standards of biological product quality and safety. With a Pharm.D. and a...
Serge Monpoeho currently serves as the Senior Director of Quality Control (QC) at Regeneron Pharmaceuticals Inc., where he leverages his extensive technical knowledge and experience in the biopharmaceutical industry to ensure the highest standards of biological product quality and safety. With a Pharm.D. and a Ph.D. in Virology, Serge brings over 15 years of expertise in cGMP environments, focusing on the realization of advanced therapy medicinal products (ATMPs) such as viral vectors, CRISPR, and siRNA products. His role encompasses not only the oversight of QC operations but also the strategic leadership necessary for effective business planning and resource synchronization.
In his capacity as Executive Director QC and Chief Virologist, Serge is instrumental in sustaining the viral safety program for monoclonal antibodies (mAbs) and ATMPs, ensuring compliance with regulatory standards and industry best practices. He plays a pivotal advisory role to senior management, providing insights into the technical aspects of gene therapy and virotherapy, which are critical for the successful development and commercialization of innovative therapies. His proficiency in validation techniques, PCR, qPCR, and ELISA, combined with a deep understanding of biochemistry and LIMS systems, positions him as a key figure in driving quality initiatives at Regeneron.
Serge’s commitment to problem-solving and continuous improvement not only enhances product realization but also fosters a culture of excellence within the QC team. His leadership in developing and implementing standard operating procedures (SOPs) ensures that the organization remains at the forefront of biotechnological advancements, ultimately contributing to the delivery of safe and effective therapies to patients.